Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal intelligence from Strategic Transactions.
Undergoing a transformation from a drug developer to a contract development and manufacturing organization, Avid Bioservices Inc.sold off its...